PDS Biotechnology Corporation (PDSB) vs Shoulder Innovations, Inc. (SI)
A side-by-side comparison of PDS Biotechnology Corporation and Shoulder Innovations, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 30, 2026. Differences are shown without an overall score or investment verdict.
PDSB
PDS Biotechnology Corporation
$0.21HealthcareAt close: Aug 28, 2026, 4:00 PM ET
SI
Shoulder Innovations, Inc.
$21.16HealthcareAt close: Aug 28, 2026, 4:00 PM ET
Total return — PDSB vs SI
growth of $100 · dividends reinvested · last 1yPDSB -80.3% (-80.3%/yr)SI +40.6% (+40.6%/yr)SI compounded faster over this window
Log scale — wide-divergence pair
PDSB SI
PDSB vs SI: by the numbers
- •SI is the larger company ($439M vs $12M market cap).
- •Both run net losses; PDSB's is the smaller (0.00% vs -58.33% net margin).
Metrics side by side
Valuation
| Metric | PDSB | SI |
|---|---|---|
| P/S ratio | N/A | 7.31 |
| P/B ratio | 3.45 | 3.53 |
| EV / EBITDA | 0.02 | N/A |
Profitability
| Metric | PDSB | SI |
|---|---|---|
| Gross margin | 0.00% | 77.34% |
| Operating margin | 0.00% | -58.53% |
| Net margin | 0.00% | -58.33% |
| ROE | -372.85% | -28.18% |
| ROIC | -3699.99% | -25.26% |
Growth (annualized)
| Metric | PDSB | SI |
|---|---|---|
| Total return CAGR (5Y) | -57.05% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 30, 2026.